Kuaishou Technology (abbrev. “Kuaishou”) announced that subsidiary Beijing Kling has closed additional financing that exhausts its previously approved subscription limit. Two new investors—China Artificial Intelligence Industry Investment Fund Partnership (“China AI Fund”) and Hong Kong-based Charoen Pokphand Robot Limited—entered the Capital Increase Agreement on 31 August 2026, committing RMB1.40 billion and USD19.29 million (approximately RMB131.45 million) respectively. Both parties also received contractual redemption rights identical to those granted to earlier investors.
Re-opened allocations for several existing investors resulted in a net change of roughly RMB84 million, with the most notable adjustments including: • Party C lifting its commitment to USD15.00 million (about RMB102.24 million). • Tianjin Lisi Xingque increasing to RMB936.96 million. • HUNDREDS PLUS LIMITED PARTNERSHIP trimming to USD30.00 million (about RMB204.47 million). • PMF Select Polaris LP reducing to USD39.00 million (about RMB265.81 million).
Following these changes, the total cash to be injected into Beijing Kling stands at RMB20.45 billion, translating into registered capital of RMB96.18 million once all subscriptions and subsidiary share participation schemes are fully executed.
Post-transaction ownership structure (equity interests): • Lucky Labs: 66.33% • Beijing Kuailingrui: 2.00% • Employee incentive vehicles and share option pools: 12.50% combined • External investors (including the newly joined China AI Fund at 1.14% and Charoen Pokphand Robot at 0.11%): 19.17%
Voting rights differ due to weighted structures; Lucky Labs retains 52.23% of the vote.
Corporate housekeeping measures include the novation of CAS GENERATION’s interests to Beijing CAS Wentian Technology Development Center (LP) and BFIH’s interests to BFI MIDCO Holding Limited, with no change to commercial terms.
All amended subscriptions fall below the 0.1% thresholds stipulated in Hong Kong’s Listing Rules and are therefore exempt from additional reporting, circular or shareholder-approval requirements.
The board confirms that, except for the updates specified, all other provisions of the Capital Increase Agreement and related Shareholders’ Agreement remain unchanged.